BCL2 and diffuse large B-cell lymphoma: Particularly, we have documented a high incidence (70%) of (14;18) translocations, affecting the anti-apoptotic gene BCL2, in the group of patients with BM infiltration and GCB-DLBCL subtype, while the frequency reported in GCB-DLBCL, irrespective of BM infiltration, is 18%–35% [29,30].